Lamivudine without HBIg for prevention of graft reinfection by hepatitis B: Long-term follow-up

Transplantation

Volumn 70, Issue 5, 2000, Pages 809-815

  Mutimer, David ^a   Dusheiko, Geoffrey ^b   Barrett, Catherine ^c   Grellier, Leonie ^b   Ahmed, Monz ^b   Anschuetz, Gaya ^c   Burroughs, Andrew ^b   Hubscher, Stefan ^a   Dhillon, Amar Paul ^b   Rolles, Keith ^b   Elias, Elwyn ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b ROYAL FREE HOSPITAL   (United Kingdom)

^c GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIBODY; HEPATITIS B(E) ANTIGEN; LAMIVUDINE; VIRUS DNA;

ADULT; AGED; ANTIBODY DETECTION; ANTIGEN DETECTION; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; GRAFT INFECTION; HEPATITIS B; HUMAN; IMMUNOPROPHYLAXIS; INFECTION PREVENTION; LIVER FUNCTION; LIVER TRANSPLANTATION; LONG TERM CARE; MALE; MULTICENTER STUDY; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; REINFECTION; SURVIVAL TIME; VIRUS DETECTION;

EID: 0034666268     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200009150-00018     Document Type: Article

References (18)

1. Survival in chronic hepatitis B: An analysis of 379 patients
2. Orthotopic liver transplantation for patients with hepatitis B virus-associated liver disease
3. Liver transplantation for patients with hepatitis B: What have we learned from our results?
4. Hepatitis B virus reinfection after orthotopic liver transplantation: Serological and clinical implications
5. Recurrence of hepatitis B and delta hepatitis after orthotopic liver transplantation
6. Liver transplantation in European patients with hepatitis B surface antigen
7. Liver transplantation for hepatitis-B virus associated cirrhosis: A progress report
8. The need for a Consensus agreement on indications of liver transplantation
9. 'EUROHEP' consensus report on the management of liver transplantation for hepatitis B virus infection
10. Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis
11. Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin
12. Multicenter study of lamivudine therapy for hepatitis B after liver transplantation
13. Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine
14. Two sensitive PCR-based methods for the detection of hepatitis B virus variants associated with reduced susceptibility to lamivudine
15. High pre-treatment serum hepatitis B virus titre predicts failure of lamivudine prophylaxis and graft re-infection after liver transplantation
16. Multicenter study of lamivudine therapy for hepatitis B after liver transplantation
17. Clinical significance of YMDD mutant hepatitis B virus (HBV) in a large cohort of lamivudine-treated hepatitis B patients